Classification and possible mechanisms of action of some drugs that inhibit platelet aggregation.
D015105:3',5'-Cyclic-AMP Phosphodiesterases / Q000097:blood; D000244:Adenosine Diphosphate / Q000378:metabolism; D000255:Adenosine Triphosphate / Q000097:blood; D000262:Adenylyl Cyclases / Q000097:blood; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D000925:Anticoagulants / Q000145:classification / Q000494:pharmacology*; D000929:Antidepressive Agents, Tricyclic / Q000494:pharmacology; D003094:Collagen / Q000494:pharmacology; D003911:Dextrans / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology; D005665:Furosemide / Q000494:pharmacology; D006487:Hemostasis / Q000187:drug effects; D006801:Humans; D009538:Nicotine / Q000494:pharmacology; D009582:Nitrofurantoin / Q000494:pharmacology; D010974:Platelet Aggregation / Q000187:drug effects*; D011121:Polyphloretin Phosphate / Q000494:pharmacology; D012701:Serotonin / Q000494:pharmacology; D013442:Sulfinpyrazone / Q000494:pharmacology; D013917:Thrombin / Q000494:pharmacology; D014667:Vasopressins / Q000494:pharmacology
D000893:Anti-Inflammatory Agents; D000925:Anticoagulants; D000929:Antidepressive Agents, Tricyclic; D003911:Dextrans; D014667:Vasopressins; D012701:Serotonin; D000244:Adenosine Diphosphate; D009538:Nicotine; D005665:Furosemide; D000255:Adenosine Triphosphate; D003094:Collagen; D011121:Polyphloretin Phosphate; D009582:Nitrofurantoin; D015105:3',5'-Cyclic-AMP Phosphodiesterases; D013917:Thrombin; D000262:Adenylyl Cyclases; D013442:Sulfinpyrazone; D004837:Epinephrine